Deals
CareTrust Lifts Earnings Forecast — Adjusted Earnings Per Share Grow 20%
The healthcare-property owner has invested about $2.9 billion this year and added borrowing capacity for more acquisitions.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Deals
The healthcare-property owner has invested about $2.9 billion this year and added borrowing capacity for more acquisitions.
Earnings
Cloud revenue grew 31%, while Atlassian projects subscription growth of approximately 18.5% for fiscal 2027.
Earnings
Record rides and bookings accompanied higher adjusted earnings, while legal, tax and regulatory items cost $117.9 million.
Earnings
Dollar General and other distribution partners are expected to offset Costco’s pullback, with the impact concentrated in the first quarter.
Earnings
RECELL sales led third-quarter growth, while another $10 million in borrowing helped ease management’s concerns about staying in business.
Earnings
Management cuts its commercial growth outlook but raises the floor for total revenue growth as its partner channel contributes more.
SEC Filings
A $100 million Genentech payment and an October share sale are expected to help fund operations into the second half of 2029.
SEC Filings
Exon-skipping drugs lifted the sales forecast floor, while a smaller research bill helped narrow the quarterly loss.
SEC Filings
The medical-products maker kept its 2026 forecast intact but expects results toward the higher end of its ranges.
Earnings
Melanoma results expand the evidence behind its individualized cancer therapy, but deeper patient analysis still has limits.
SEC Filings
Veppanu brought in $6.6 million in initial sales, while Rigel narrowed its annual revenue outlook, which excludes the breast-cancer drug.
SEC Filings
Gilbert will take over January 1 while TransUnion continues its search for a permanent finance chief.